Threads about different articles have been merged
Article about today's protest at the White House from MedPage Today:
"Long COVID, ME/CFS Patients Protest in Front of White House"
https://www.medpagetoday.com/infectiousdisease/longcovid/100806
There was also a mention of the protest, and...
https://www.nytimes.com/2021/07/24/technology/joseph-mercola-coronavirus-misinformation-online.html?action=click&module=Spotlight&pgtype=Homepage
The Most Influential Spreader of Coronavirus Misinformation Online
Researchers and regulators say Joseph Mercola, an osteopathic physician, creates...
https://www.nytimes.com/2021/05/28/opinion/alzheimer-treatment-FDA-aducanumab.html?action=click&module=Opinion&pgtype=Homepage
They’ve spent billions on Alzheimer’s and sounds like they still have nothing. Worth reading even though it’s not about MECFS.
Article looking at effect of exercise on older females with RA.
Not much of a study, but interesting
Why Exercise Can Be So Draining for People With Rheumatoid Arthritis - The New York Times (nytimes.com)
https://www.nytimes.com/2019/12/07/us/dna-bone-marrow-transplant-crime-lab.html
Interesting... wonder if pwmecfs could benefit from a bone marrow transplant, especially since all of the blood will have the donor’s genotype. In other words, maybe the blood after transplant won’t have...
The New York Times: Why Doctors Still Offer Treatments That May Not Help by Austin Frakt
Even when we learn something doesn’t make us better, it’s hard to get the system to stop doing it. It takes years or even decades to reverse medical convention. Some practitioners cling to weak evidence of...
New York Times article about Stanford research published in Nature and led by Mike Snyder whose team is also helping Ron Davis with multiomics. This study was a very long longitudinal study to capture changes in the body over time, before diseases were diagnosed. Some changes led to early...
https://www.nytimes.com/2019/03/15/opinion/preventing-mental-illness.html
This is an opinion piece that endorses the Biopsychosocial model for understanding mental/psychiatric illness.
We are primed to react negatively to "BPS" because it is used as an assertion to frame CFS and other 'MUS'...
https://www.nytimes.com/2019/03/16/opinion/sunday/pain-opioids.html
I saw this in the opinions today. It's a short read and I must say it is fluff.
Summary:
-The author notes that opioids have proven to be ineffective and even counterproductive for treating chronic pain (okay).
-From that...
Aaron E. Carroll: Peer Review: The Worst Way to Judge Research, Except for All the Others
One way to detect problems with research earlier would be to let researchers post manuscripts online before submission, for public judgment before formal peer review. This is already common in some...
"Researchers should embrace negative results instead of accentuating the positive, which is one of several biases that can lead to bad science."
"When we think of biases in research, the one that most often makes the news is a researcher’s financial conflict of interest. But another bias, one...
https://www.nytimes.com/2018/09/08/health/jose-baselga-cancer-memorial-sloan-kettering.html?rref=collection/sectioncollection/world&action=click&contentCollection=world®ion=stream&module=stream_unit&version=latest&contentPlacement=9&pgtype=sectionfront
See also the related articles noted at...
Vitamin D, the Sunshine Supplement, Has Shadowy Money Behind It
The doctor most responsible for creating a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry.
"The Six Habits of Highly Respectful Physicians" by Michael W. Kahn
New York Times, DEC. 1, 2008
Not "News", yet still deserves attention IMO.The author is one of the few psychiatrists who signed Vincent Racaniello's / David Tuller's Open letter to the Lancet*...
"Funding is harder to find in general, and the current approach favors low-risk research and proposals by older scientists...."
https://mobile.nytimes.com/2018/06/18/upshot/why-the-medical-research-grant-system-could-be-costing-us-great-ideas.html
My 2011 NY Times Exchange With the PACE PIs
When the PACE trial was published in early 2011, my New York Times editor sent it to me, along with the press release. As a non-staff contributor to the Times, I had started covering the debate over the mouse retrovirus hypothesis and science, but I’d...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.